Opera Trading Capital bought a new position in Monsanto Company (NYSE:MON) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 11,130 shares of the company’s stock, valued at approximately $1,334,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Vanguard Group Inc. raised its holdings in Monsanto by 2.6% in the 2nd quarter. Vanguard Group Inc. now owns 30,725,725 shares of the company’s stock worth $3,636,697,000 after acquiring an additional 784,418 shares during the period. BlackRock Inc. raised its holdings in Monsanto by 6.5% in the 2nd quarter. BlackRock Inc. now owns 27,898,255 shares of the company’s stock worth $3,302,038,000 after acquiring an additional 1,705,439 shares during the period. State Street Corp raised its holdings in Monsanto by 0.6% in the 2nd quarter. State Street Corp now owns 20,276,780 shares of the company’s stock worth $2,399,965,000 after acquiring an additional 122,814 shares during the period. Northern Trust Corp raised its holdings in Monsanto by 0.7% in the 2nd quarter. Northern Trust Corp now owns 7,092,929 shares of the company’s stock worth $839,519,000 after acquiring an additional 47,725 shares during the period. Finally, Flossbach Von Storch AG raised its holdings in Monsanto by 7.5% in the 2nd quarter. Flossbach Von Storch AG now owns 4,397,000 shares of the company’s stock worth $520,429,000 after acquiring an additional 307,600 shares during the period. Hedge funds and other institutional investors own 74.50% of the company’s stock.

Several research firms have issued reports on MON. Zacks Investment Research lowered shares of Monsanto from a “buy” rating to a “hold” rating in a research report on Tuesday, September 12th. Wells Fargo & Company raised their price target on shares of Monsanto from $107.50 to $118.00 and gave the stock a “market perform” rating in a research report on Tuesday, October 10th. UBS AG lowered shares of Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 price target on the stock. in a research report on Friday, August 18th. BidaskClub upgraded shares of Monsanto from a “sell” rating to a “hold” rating in a research report on Saturday, August 19th. Finally, Barclays PLC restated an “equal weight” rating and issued a $124.00 price target (up from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. Eleven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of C$124.61.

WARNING: This news story was published by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another site, it was stolen and republished in violation of US and international trademark and copyright law. The legal version of this news story can be viewed at https://www.watchlistnews.com/opera-trading-capital-buys-new-holdings-in-monsanto-company-mon/1700242.html.

In related news, VP Duraiswami Narain sold 2,860 shares of Monsanto stock in a transaction dated Monday, September 25th. The shares were sold at an average price of C$120.00, for a total transaction of C$343,200.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Brett D. Begemann sold 22,640 shares of Monsanto stock in a transaction dated Monday, September 25th. The shares were sold at an average price of C$120.03, for a total transaction of C$2,717,479.20. Following the transaction, the chief operating officer now directly owns 85,439 shares of the company’s stock, valued at C$10,255,243.17. The disclosure for this sale can be found here. Insiders have sold a total of 49,236 shares of company stock valued at $5,931,934 over the last three months. 0.79% of the stock is currently owned by insiders.

Shares of Monsanto Company (NYSE MON) traded down C$0.09 during mid-day trading on Monday, reaching C$118.21. 426,320 shares of the company traded hands, compared to its average volume of 1,937,834. Monsanto Company has a 12-month low of C$97.35 and a 12-month high of C$122.79. The company has a market cap of $52,075.66, a P/E ratio of 21.39, a P/E/G ratio of 1.70 and a beta of 1.05. The company has a quick ratio of 0.83, a current ratio of 1.35 and a debt-to-equity ratio of 1.12.

Monsanto (NYSE:MON) last announced its quarterly earnings results on Wednesday, October 4th. The company reported C$0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of C($0.41) by C$0.61. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The firm had revenue of C$2.69 billion during the quarter, compared to the consensus estimate of C$2.51 billion. During the same period last year, the firm posted $0.07 EPS. The firm’s quarterly revenue was up 4.8% on a year-over-year basis. equities research analysts predict that Monsanto Company will post 5.74 earnings per share for the current year.

Monsanto Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with Analyst Ratings Network's FREE daily email newsletter.